Evidence map›Paper›PMID 24521561›Full record

Trial reportThe British journal of nutrition2014

Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial.

Francesco Sofi, Anne Whittaker, Anna Maria Gori, Francesca Cesari, Elisabetta Surrenti, Rosanna Abbate, Gian Franco Gensini, Stefano Benedettelli, Alessandro Casini

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The British journal of nutrition, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06191432 (Tolerability of an Ancient Grain in Patients With Non-Celiac Wheat Sensitivity. A Clinical Study and a Search for Diagnostic Biomarkers.), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06191432 narecruitingnot on this mapstarted 2024, after this paper: background citation

Tolerability of an Ancient Grain in Patients With Non-Celiac Wheat Sensitivity. A Clinical Study and a Search for Diagnostic Biomarkers.

TypeinterventionalSponsorUniversity of PalermoRan2024 to 2026Enrolled68ConditionsNon-celiac Gluten SensitivityArmsAdministration of Triticum Monococcum flour, Administration of Triticum Aestivum flour
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Francesco SofiAgency of Nutrition, Careggi University Hospital,Florence,Italy.
Anne WhittakerInterdipartimental Center for Research on Food and Nutrition, University of Florence,Florence,Italy.
Anna Maria GoriDepartment of Experimental and Clinical Medicine,University of Florence,Largo Brambilla 3,Florence50134,Italy.
Francesca CesariDepartment of Experimental and Clinical Medicine,University of Florence,Largo Brambilla 3,Florence50134,Italy.
Elisabetta SurrentiDigestive Pathophysiology and Motility Unit, Careggi University Hospital,Florence,Italy.
Rosanna AbbateDepartment of Experimental and Clinical Medicine,University of Florence,Largo Brambilla 3,Florence50134,Italy.
Gian Franco GensiniDepartment of Experimental and Clinical Medicine,University of Florence,Largo Brambilla 3,Florence50134,Italy.
Stefano BenedettelliInterdipartimental Center for Research on Food and Nutrition, University of Florence,Florence,Italy.
Alessandro CasiniAgency of Nutrition, Careggi University Hospital,Florence,Italy.
University of Florence · ITDon Carlo Gnocchi Foundation · ITAzienda Ospedaliero-Universitaria Careggi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to examine the effect of a replacement diet with organic, semi-whole-grain products derived from Triticum turgidum subsp. turanicum (ancient) wheat on irritable bowel syndrome (IBS) symptoms and inflammatory/biochemical parameters. A double-blinded randomised cross-over trial was performed using twenty participants (thirteen females and seven males, aged 18-59 years) classified as having moderate IBS. Participants received products (bread, pasta, biscuits and crackers) made either from ancient or modern wheat for 6 weeks in a random order. Symptoms due to IBS were evaluated using two questionnaires, which were compiled both at baseline and on a weekly basis during the intervention period. Blood analyses were carried out at the beginning and end of each respective intervention period. During the intervention period with ancient wheat products, patients experienced a significant decrease in the severity of IBS symptoms, such as abdominal pain (P< 0·0001), bloating (P= 0·004), satisfaction with stool consistency (P< 0·001) and tiredness (P< 0·0001). No significant difference was observed after the intervention period with modern wheat products. Similarly, patients reported significant amelioration in the severity of gastrointestinal symptoms only after the ancient wheat intervention period, as measured by the intensity of pain (P= 0·001), the frequency of pain (P< 0·0001), bloating (P< 0·0001), abdominal distension (P< 0·001) and the quality of life (P< 0·0001). Interestingly, the inflammatory profile showed a significant reduction in the circulating levels of pro-inflammatory cytokines, including IL-6, IL-17, interferon-γ, monocyte chemotactic protein-1 and vascular endothelial growth factor after the intervention period with ancient wheat products, but not after the control period. In conclusion, significant improvements in both IBS symptoms and the inflammatory profile were reported after the ingestion of ancient wheat products.

Indexed as

DietTriticumAdolescentAdultAgedBody Mass IndexChemokine CCL2Cross-Over StudiesDouble-Blind MethodFemaleHumansInterferon-gammaInterleukin-17Interleukin-6Irritable Bowel SyndromeMaleCCL2 protein, humanChemokine CCL2IFNG protein, humanIL6 protein, humanInterferon-gammaInterleukin-17Interleukin-6Vascular Endothelial Growth Factor AVEGFA protein, humanCytokinesDietsGrainsIrritable bowel syndromeWheat

Identifiers

PMID24521561
PMCPMC4405706
OpenAlexW2123701706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.